Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLloyds Regulatory News (LLOY)

Share Price Information for Lloyds (LLOY)

Share Price is delayed by 15 minutes
Get Live Data
98.90    -1.20 (-1.20%)
Bid:
99.22
Ask:
99.28
Spread: 0.06 (0.06%)
Market Cap: £57.64b
LLOY Live PriceLast checked at - London Stock Exchange

Intraday Lloyds Share Chart

Board Change

5 Jun 2025 12:20

RNS Number : 6476L
Lloyds Banking Group PLC
05 June 2025
 

5 June 2025

LLOYDS BANKING GROUP: BOARD CHANGE

Lloyds Banking Group plc (the "Group") is pleased to announce the appointment of Chris Vogelzang as an independent Non-Executive Director and a member of the Responsible Business Committee, in each case with effect from 16 June 2025.

BIOGRAPHICAL DETAILS

Chris has extensive experience in retail and commercial banking. He possesses a strong understanding of technology's role in financial services and has a track record of driving transformation within organisations.

Chris was Chief Executive Officer of Danske Bank A/S from 2019 until 2021. He held a number of senior positions at ABN AMRO between 2000 and 2016, including Managing Board member with responsibility for Retail and Private Banking, Chief Executive Officer of Retail Banking for The Netherlands and Chief Executive Officer of Global Private Banking.

Chris is currently a Non-Executive Director and a member of the Audit Committee of Wolters Kluwer N.V., which is listed on Euronext Amsterdam, and a senior advisor (financial services) to Boston Consulting Group and to The Blackstone Group.

There is no other information to be disclosed under UK Listing Rule 6.4.8R.

- END -

For further information:

Investor Relations

Douglas Radcliffe

Group Investor Relations Director

Email: douglas.radcliffe@lloydsbanking.com

 

Group Corporate Affairs

Matt Smith

Head of Media Relations

Email: matt.smith@lloydsbanking.com

 

+44 (0) 20 7356 1571

 

 

 

+44 (0) 7788 352 487

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAPKPBDDBKDCAK
Date   Source Headline
10th Dec 20254:39 pmRNSDirector/PDMR Shareholding
9th Dec 20254:00 pmRNSDirector/PDMR Shareholding
9th Dec 20257:03 amRNSCompletion of £1.7 billion Share Buyback Programme
8th Dec 20255:42 pmRNSTransaction in Own Shares
5th Dec 20255:50 pmRNSTransaction in Own Shares
4th Dec 20255:38 pmRNSTransaction in Own Shares
3rd Dec 20255:44 pmRNSTransaction in Own Shares
2nd Dec 20255:35 pmRNSTransaction in Own Shares
2nd Dec 20257:39 amRNSBoE Stress Test Passed
1st Dec 20255:31 pmRNSTransaction in Own Shares
28th Nov 20254:12 pmRNSTotal Voting Rights
27th Nov 20255:34 pmRNSTransaction in Own Shares
26th Nov 20255:38 pmRNSTransaction in Own Shares
25th Nov 20255:20 pmRNSTransaction in Own Shares
24th Nov 20255:41 pmRNSTransaction in Own Shares
21st Nov 20255:43 pmRNSTransaction in Own Shares
21st Nov 20253:00 pmRNSDirector/PDMR Shareholding
20th Nov 20255:28 pmRNSTransaction in Own Shares
20th Nov 20253:00 pmRNSBlock Listing of Shares
19th Nov 20255:38 pmRNSTransaction in Own Shares
19th Nov 20251:20 pmRNSDirector Declaration
19th Nov 20257:00 amRNSCurve Acquisition
18th Nov 20255:35 pmRNSTransaction in Own Shares
17th Nov 20255:40 pmRNSTransaction in Own Shares
14th Nov 20255:53 pmRNSTransaction in Own Shares
13th Nov 20255:27 pmRNSTransaction in Own Shares
12th Nov 20255:32 pmRNSTransaction in Own Shares
11th Nov 20255:33 pmRNSTransaction in Own Shares
11th Nov 20253:40 pmRNSDirector/PDMR Shareholding
10th Nov 20255:35 pmRNSTransaction in Own Shares
7th Nov 20255:42 pmRNSTransaction in Own Shares
6th Nov 20255:39 pmRNSTransaction in Own Shares
6th Nov 20252:33 pmRNSPublication of Final Terms
6th Nov 202510:32 amRNSDirector/PDMR Shareholding
5th Nov 20255:34 pmRNSTransaction in Own Shares
4th Nov 20255:42 pmRNSTransaction in Own Shares
3rd Nov 20255:45 pmRNSTransaction in Own Shares
31st Oct 20255:47 pmRNSTransaction in Own Shares
31st Oct 20254:38 pmRNSTotal Voting Rights
30th Oct 20255:16 pmRNSTransaction in Own Shares
29th Oct 20255:40 pmRNSTransaction in Own Shares
29th Oct 202510:31 amRNSNotification of Redemption
28th Oct 20255:29 pmRNSTransaction in Own Shares
27th Oct 20255:29 pmRNSTransaction in Own Shares
24th Oct 20255:56 pmRNSTransaction in Own Shares
24th Oct 202511:33 amRNSPublication of Suppl.Prospcts
24th Oct 20259:30 amRNSPublication of Suppl.Prospcts
23rd Oct 20255:49 pmRNSTransaction in Own Shares
23rd Oct 202512:25 pmRNSPublication of Suppl.Prospcts
23rd Oct 202511:58 amRNS2025 Q3 Interim Management Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.